Europe’s Drug Regulator Is Backing Away From the U.K.
- Potential split sparks concern about delays, patient access
- Agency’s boss says too much reliance on one nation is mistake
This article is for subscribers only.
Europe’s medicines watchdog is bracing to make do without one of its most trusted partners.
The European Medicines Agency stopped assigning work to the U.K.’s pharmaceutical regulator earlier this year, unsure whether the two organizations will need to stop collaborating after Britain leaves the European Union in March. Preparing for a potential split, the EU body has also handed over responsibility for about 370 drugs that were overseen by the British authority to other countries.